[EN] NOVEL SALT FORM OF A ß2 -ADRENERGIC AGONIST QUINOLIN-2-ONE DERIVATIVE<br/>[FR] NOUVELLE FORME SALINE D'UN DERIVE DE QUINOLIN-2-ONE AGISSANT COMME AGONISTE $G(B)2-ADRENERGIQUE
申请人:GLAXO GROUP LTD
公开号:WO2006133942A1
公开(公告)日:2006-12-21
[EN] The present invention relates to the preparation of a ß2 adrenergic agonist in crystalline salt form. In particular the invention relates to a crystalline 2, 5-dichlorbenzenesulf onate salt of N- [2- [4- [ (3-phenyl-4-methoxyphenyl) amino] phenyl] ethyl] - (R) -2-hydroxy-2- (8-hydroxy-1, 2-dihydro-2 -oxoquinolin-5-yl) ethylamine.
[FR] La présente invention concerne la préparation d'un agoniste ß2-adrénergique sous forme de sel cristallin. Plus particulièrement, l'invention concerne un sel de 2,5-dichlorobenzènesulfonate de N-[2-[4-[(3-phényl-4-méthoxyphényl)amino]phényl]éthyl]-(R)-2-hydroxy-2-(8-hydroxy-1,2-dihydro-2-oxoquinolin-5-yl)éthylamine.